Guardant Health
GH
#3235
Rank
S$4.92 B
Marketcap
$39.83
Share price
1.26%
Change (1 day)
29.42%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Earnings for Guardant Health (GH)

Earnings in 2024 (TTM): -S$0.66 Billion

According to Guardant Health 's latest financial reports the company's current earnings are S$0.64 Billion. In 2023 the company made an earning of -S$0.65 Billion, an increase over its 2022 earnings that were of -S$0.88 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Guardant Health from 2018 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$0.66 Billion2.63%
2023 -S$0.65 Billion-26.73%
2022 -S$0.88 Billion69.96%
2021 -S$0.52 Billion56.35%
2020 -S$0.33 Billion252.69%
2019 -S$93.41 Million-17.22%
2018 -S$0.12 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$0.39 Billion-40.77%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$42.31 Million-93.56%๐Ÿ‡บ๐Ÿ‡ธ USA